What were the primary findings of the ACCORD trial?
The primary findings of the ACCORD trial were that intensive glucose control did not reduce the risk of death in patients with type 2 diabetes compared to standard glucose control strategies. Additionally, intensive glucose control was associated with an increased risk of adverse events such as hypoglycemia and weight gain.